Balázs Sümegi

Title: Balázs Sümegi: Innovator in Cancer Treatment

Introduction

Balázs Sümegi is a notable inventor based in Pécs, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 7 patents, his work focuses on innovative compounds that have the potential to improve therapeutic outcomes for patients.

Latest Patents

One of his latest patents is for desethylamiodarone, a compound that is being explored for its use in cancer treatment. This invention relates to a compound selected from the group consisting of desethylamiodarone and its pharmaceutically acceptable salts, hydrates, and solvates. The pharmaceutical composition includes this compound along with a suitable excipient, vehicle, or carrier for effective cancer treatment.

Another significant patent involves quinazolinone-derivatives, which are designed for the preparation of pharmaceutical compositions that have a PARP enzyme inhibitory effect. These quinazoline derivatives and their pharmaceutically acceptable salts are capable of inhibiting a DNA-repairing enzyme known as poly(ADP-ribose) polymerase (PARP). This inhibition can be beneficial in preventing or treating various illnesses.

Career Highlights

Throughout his career, Balázs Sümegi has worked with reputable organizations such as N-Gene Research Laboratories, Inc. and the University of Pécs. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

He has collaborated with notable colleagues, including Zita Bognár and Ferenc Gallyas, Jr. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Balázs Sümegi is a prominent figure in the field of pharmaceutical innovation, particularly in cancer treatment. His patents reflect a commitment to advancing medical science and improving patient care. His work continues to inspire future innovations in the industry.